13
Participants
Start Date
September 15, 2020
Primary Completion Date
July 31, 2023
Study Completion Date
September 1, 2025
Insulin
Participants will be asked to dose insulin during the first week using fixed doses. During the second week of the study, participants will dose insulin based on carbohydrate counting. Blood sugar control will be compared between the 2 weeks to determine the outcomes of the study.
Continuous glucose monitor (CGM)
Participants will be required to wear a CGM to measure glucose trends
University of Pittsburgh Medical Center, Center for Diabetes and Endocrinology, Pittsburgh
Wake Forest University Health Sciences
OTHER
Jagdeesh Ullal
OTHER